Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2000
10/05/2000CA2366604A1 Modulators of polysaccharides and uses thereof
10/05/2000CA2366012A1 Methods of treating leukemia
10/05/2000CA2364305A1 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same
10/04/2000EP1041068A1 Compounds for treating and preventing diabetic complications
10/04/2000EP1040831A2 Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
10/04/2000EP1040829A2 Prokinetic agents for treating gastric hypomotility and related disorders
10/04/2000EP1040822A1 Extensible Mask with an adhesive matrix which is at least stretchable when wetted
10/04/2000EP1040200A1 Virulence-associated nucleic acid sequences and uses thereof
10/04/2000EP1040196A2 Transgenic animal model for degenerative diseases of cartilage
10/04/2000EP1040194A1 Human signal transduction serine/threonine kinase
10/04/2000EP1040191A2 Rantes mutants and therapeutic applications thereof
10/04/2000EP1040183A1 Nucleic acid encoding mammalian ubr1
10/04/2000EP1040126A2 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
10/04/2000EP1040111A1 Integrin receptor antagonists
10/04/2000EP1039927A1 UGC (UPSTREAM GENE OF cdsA)
10/04/2000EP1039925A1 Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells
10/04/2000EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension
10/04/2000EP1039906A1 Novel metal complexes
10/04/2000EP1039904A1 Synergistic antimicrobial compositions
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1039891A1 Treatment of scar tissue using lipoic acid
10/04/2000EP1039890A1 Novel salts of metformin and method
10/04/2000EP1039887A1 Methods for treatment of neuro- and nephro-disorders and therapeutic toxicities using aminothiol compounds
10/04/2000EP1039884A1 A method for the prevention and treatment of stunned myocardium
10/04/2000EP1039874A1 Compositions and methods for treatment of alopecia
10/04/2000EP1039802A1 Transdermal therapeutic device and method with capsaicin and capsaicin analogs
10/04/2000EP0772439B1 Novel antibiotic compounds and antibiotic compositions comprising said compounds for inhibiting gram positive bacteria and mycoplasma cells.
10/04/2000CN1269013A Moleculars withch give out multiple active parts
10/04/2000CN1268980A Novel screening methods to identify agents that selectively inhibit hepatitis C virus replication
10/04/2000CN1268954A method and compositions for treating abnormal cell growth relating to unwanted guanine nucleotide exchange factor activity
10/04/2000CN1056973C Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it
10/03/2000US6128582 Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them
10/03/2000US6127522 CRFG-1a, a target and marker for chronic renal failure
10/03/2000US6127410 Compositions, apparatus and methods for facilitating surgical procedures
10/03/2000US6127393 An antagonist deactivating a protein having a transition metal ion-protein complex; a metal chelating agent
10/03/2000US6127387 Use of CD4-binding small molecules to inhibit immune responses
10/03/2000US6127385 Administering ritalin orally or non-orally to a patient as antidepressant
10/03/2000US6127370 Method for treating alzheimer's disease
10/03/2000US6127367 Administering an aldose reductase inhibitor as an antiischemic agent
10/03/2000US6127363 Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
10/03/2000US6127351 Method for the administration of amifostine and related compounds
10/03/2000US6127349 For increasing the water solubility and bioavailability of pharmaceutical agents by conjugation to phospholipids
10/03/2000US6127345 Utilizing glucose 6-phosphate dehydrogenase gene polypeptide for the protection against infection, particularly bacterial infections
10/03/2000US6127116 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
10/03/2000US6126947 Method for the treatment of skin disorders using inhibitor of cholesterol synthesis
10/03/2000US6126937 Clpl polypeptides, polynucleotides encoding clpl polypeptides and methods for producing such polypeptides by recombinant techniques.
10/03/2000US6126936 Microcapsules and composite microreactors for immunoisolation of cells
10/03/2000CA2006953C Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids.
09/2000
09/28/2000WO2000057190A2 Prediction of diabetes impaired wound healing
09/28/2000WO2000057187A2 Diagnosis and treatment of multiple sclerosis
09/28/2000WO2000057186A1 Method for detecting predisposition to a venous thromboembolic disease
09/28/2000WO2000057185A1 Method for detecting superantigen activity in a biological sample
09/28/2000WO2000056919A1 Screening method involving mgdg synthase
09/28/2000WO2000056899A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000WO2000056894A1 Fungal beta-tubulin genes
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056880A1 50 human secreted proteins
09/28/2000WO2000056864A2 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1)
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056773A1 Antibodies specific for cyp1b1
09/28/2000WO2000056765A1 48 human secreted proteins
09/28/2000WO2000056737A2 Calanolides for inhibiting btk
09/28/2000WO2000056729A1 Chemokine recpetor binding heterocyclic compounds
09/28/2000WO2000056464A1 Atomising nozzle
09/28/2000WO2000056405A2 Human tumor necrosis factor receptor-like 2
09/28/2000WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
09/28/2000WO2000056376A1 Medical devices and applications of polyhydroxyalkanoate polymers
09/28/2000WO2000056366A1 Gel-microemulsion formulations
09/28/2000WO2000056363A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
09/28/2000WO2000056362A2 Polycationic carbohydrates as immunostimulants in vaccines
09/28/2000WO2000056361A2 Vaccine composition
09/28/2000WO2000056333A1 Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance
09/28/2000WO2000056331A1 Inhibitors of impdh enzyme
09/28/2000WO2000056324A1 The use of certain affinity nmda antagonists as antidepressants
09/28/2000WO2000056304A2 Anti-inflammatory uses of manzamines
09/28/2000WO2000056301A2 Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
09/28/2000WO2000056297A2 Pharmaceutical compositions comprising dipeptidy peptidase iv inhibitors for the promotion of growth
09/28/2000WO2000056296A2 Compositions for improving fertility
09/28/2000WO2000056295A2 Oral combinations of hydroxocobalamin and folic acid
09/28/2000WO2000056282A1 Particle based vaccine composition
09/28/2000WO2000056275A1 Compositions based on chondroitin sulphate and chitosan for preventing or treating rheumatic disorders by general administration
09/28/2000WO2000056153A1 Oral low dose butyrate compositions
09/28/2000WO2000056145A1 Organ arrest, protection and preservation
09/28/2000WO2000044359A3 Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections
09/28/2000WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto
09/28/2000WO2000041497A3 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
09/28/2000WO2000029577A9 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
09/28/2000WO2000028332A9 Methods and compositions to lower plasma cholesterol levels
09/28/2000WO2000024396A9 Treatment of disorders of the outer retina
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000WO2000022142A3 Cell signaling polypeptides and nucleic acids
09/28/2000WO2000021515A3 Intranasal codeine for the rapid suppression of cough and rapid relief of pain
09/28/2000WO2000020576A3 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000WO2000013712A3 Methods and compositions for the prevention or treatment of cancer
09/28/2000WO2000013706A9 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
09/28/2000WO2000009085A3 Oral formulation containing cyclosporin
09/28/2000WO2000003741A3 Methods for reducing intraocular pressure using a3-adenosine antagonists
1 ... 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 ... 1151